[250 Pages Report] As per comprehensive research conducted by ESOMAR-certified consulting firm FMI, the global Transcatheter Heart Valve Replacement (TAVI) market is projected to witness robust growth ...

The FDA PMA for JenaValve's Trilogy device for TAVR-AR comes months after a court struck down Edwards Lifesciences attempt to ...

For all the innovation, engineering, and miniaturization that has helped to refine surgical and transcatheter aortic valve replacement over the last few decades, they still fall short of ideal. That ...

New data from the PARTNER 3 low-risk trial of patients with symptomatic, severe aortic stenosis show that TAVI and SAVR are matched in terms of how patients feel at 7 years, mirroring the long-term ...

Just a few years ago, treating critical aortic stenosis required surgery. Now, there’s transcatheter aortic valve replacement, which allows for treatment of the heart’s blocked valve without actual ...

Cardiovascular issues include conditions affecting the heart and blood vessels. Heart issues like coronary artery disease, hypertension, heart failure, and arrhythmias can be some of the many coronary ...

Transit Officer Paul DeGeorge thought his son was lying on him. Then he realized something much scarier was happening.

Future Market Insights (FMI), a Leading Market Research and Competitive Intelligence Provider Offers Exhaustive Analysis on Key Factors Burgeoning the Sales in the Global Transcatheter Heart Valve ...

The first human transcatheter aortic valve implantation (TAVI) in 2002, and several subsequent single-center series, showed the feasibility of this new approach for the treatment of patients with ...

Surgery to replace an aortic valve is done for aortic valve stenosis and aortic valve regurgitation. During this surgery, the damaged valve is removed and replaced with an artificial valve. The valve ...